Equities

Embla Medical hf

Embla Medical hf

Actions
  • Price (DKK)34.70
  • Today's Change34.70 / --
  • Shares traded4.00
  • 1 Year change+26.41%
  • Beta--
Data delayed at least 20 minutes, as of Oct 31 2024 11:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue786719719
OPERATING EXPENSES
Cost of revenue total300279263
Selling, general and admin. expenses, total336311299
Depreciation/amortization313234
Unusual expense(income)000.12
Other operating expenses, total(4.4)2.30(1.8)
Total operating expense696654621
Operating income896597
Other, net(1.6)(1.22)(2.56)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes765687
Provision for income taxes171321
Net income after taxes594366
Minority interest(0.41)(0.7)(1.66)
Net income before extra. Items584364
Total extraordinary items------
Net income584364
Inc.avail. to common excl. extra. Items584364
Inc.avail. to common incl. extra. Items584364
EPS RECONCILIATION
Basic/primary weighted average shares420418422
Basic/primary eps excl. extra items0.140.100.15
Basic/primary eps incl. extra items0.140.100.15
Dilution adjustment------
Diluted weighted average shares420418423
Diluted eps excl. extra items0.140.100.15
Diluted eps incl. extra items0.140.100.15
COMMON STOCK DIVIDENDS
DPS - common stock primary issue000
Gross dividend - common stock------
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental18119.80
SUPPLEMENTAL INCOME
Depreciation, supplemental403940
Total special items000.12
NORMALISED INCOME
Normalized income before taxes765687
Effect of special items on income taxes000.03
Income tax excluding impact of special items171321
Normalized income after tax594366
Normalized income avail. to common584364
Basic normalized EPS0.140.100.15
Diluted normalized EPS0.140.100.15
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.